Kazia Therapeutics Ltd ADR

Price & Volume

Stats

52W Range	$2.86-$17.40
Market Cap	$81.1M
Shares Short	155,365

Financials

Revenue (12 Mos)	$1.8M
Revenue Growth (YoY)	-27.2%
Gross Profit (12 Mos)	$1.8M
Diluted EPS	-$12.66

News

Yahoo Finance • 26 days ago

Kazia Therapeutics Regains Full Nasdaq Listing Compliance

Yahoo Finance • 2 months ago

Nuclear Power Surge, $10M Buyback, and a $1.9B SEO Bombshell

Yahoo Finance • 4 months ago

Discover the top movers in Thursday's pre-market session.

Yahoo Finance • 3 years ago

KAZIA'S PAXALISIB RECEIVES FAST TRACK DESIGNATION FROM FDA FOR TREATMENT OF SOLID TUMOR BRAIN METASTASES HARBORING PI3K PATHWAY MUTATIONS IN COMBINATION WITH RADIATION THERAPY

About

Address	Three International Towers, Sydney, NSW, Australia, 2000
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	6